| Thalassa Holdings Ltd (THAL) Thalassa Holdings Ltd (Reuters: THAL.L, Bloomberg: THAL:LN) (“Thalassa, “THAL” or the “Company”) Trading Update The Board of the Company wishes to announce the acquisition by the Company of 8,000,000 shares of Surgical Innovations Group plc, a UK company listed on the London Stock Exchange’s AIM, increasing the Company’s stake in Surgical Innovations Group plc to 10.80%. Surgical Innovations Group plc (AIM: SUN), ‘specialises in the design and manufacture of creative solutions for use in minimally invasive surgery (MIS) and industrial markets. [Their] pioneering products are developed in close collaboration with international surgeons to ensure they meet patients’ needs and remain at the forefront of innovation’. https://www.sigroupplc.com/ END
Dissemination of a Regulatory Announcement that contains inside information in accordance with the Market Abuse Regulation (MAR), transmitted by EQS Group. The issuer is solely responsible for the content of this announcement. |
| ISIN: | VGG878801114 |
| Category Code: | TST |
| TIDM: | THAL |
| LEI Code: | 2138002739WFQPLBEQ42 |
| Sequence No.: | 340653 |
| EQS News ID: | 1968291 |
| End of Announcement | EQS News Service |
| |
UK Regulatory announcement transmitted by EQS Group AG. The issuer is solely responsible for the content of this announcement.